TN2010000135A1 - Galenical formulations of organic compounds - Google Patents
Galenical formulations of organic compoundsInfo
- Publication number
- TN2010000135A1 TN2010000135A1 TNP2010000135A TN2010000135A TN2010000135A1 TN 2010000135 A1 TN2010000135 A1 TN 2010000135A1 TN P2010000135 A TNP2010000135 A TN P2010000135A TN 2010000135 A TN2010000135 A TN 2010000135A TN 2010000135 A1 TN2010000135 A1 TN 2010000135A1
- Authority
- TN
- Tunisia
- Prior art keywords
- minutes
- organic compounds
- galenical formulations
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97590107P | 2007-09-28 | 2007-09-28 | |
US97590907P | 2007-09-28 | 2007-09-28 | |
US97592507P | 2007-09-28 | 2007-09-28 | |
US97591907P | 2007-09-28 | 2007-09-28 | |
PCT/US2008/077416 WO2009045795A2 (fr) | 2007-09-28 | 2008-09-24 | Formulations galéniques de composés organiques |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2010000135A1 true TN2010000135A1 (en) | 2011-09-26 |
Family
ID=40377183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2010000135A TN2010000135A1 (en) | 2007-09-28 | 2010-03-26 | Galenical formulations of organic compounds |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100209480A1 (fr) |
EP (1) | EP2205233A2 (fr) |
JP (1) | JP2010540547A (fr) |
KR (1) | KR20100063090A (fr) |
CN (1) | CN101808631A (fr) |
AR (1) | AR066168A1 (fr) |
AU (1) | AU2008309058B2 (fr) |
BR (1) | BRPI0817442A2 (fr) |
CA (1) | CA2698330A1 (fr) |
CL (1) | CL2008002829A1 (fr) |
CO (1) | CO6270217A2 (fr) |
EC (1) | ECSP10010052A (fr) |
MA (1) | MA31706B1 (fr) |
MX (1) | MX2010003441A (fr) |
PE (1) | PE20090654A1 (fr) |
TN (1) | TN2010000135A1 (fr) |
TW (1) | TW200924737A (fr) |
WO (1) | WO2009045795A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0817586A2 (pt) * | 2007-09-28 | 2015-03-31 | Novartis Ag | Formulações galênicas de compostos orgânicos |
AR073651A1 (es) * | 2008-09-24 | 2010-11-24 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
US20120009257A1 (en) * | 2009-03-20 | 2012-01-12 | Indrajit Ghosh | Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren |
AR075881A1 (es) * | 2009-03-20 | 2011-05-04 | Novartis Ag | Composicion farmaceutica.metodo de preparacion |
AR080683A1 (es) * | 2010-03-16 | 2012-05-02 | Novartis Ag | Composiciones farmaceuticas de aliskiren y metodos de administracion |
TR201002256A1 (tr) * | 2010-03-24 | 2011-10-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Stabil aliskiren formülasyonları |
CN101926793B (zh) * | 2010-08-05 | 2012-08-15 | 成都自豪药业有限公司 | 一种含替米沙坦和阿利吉伦的联合用药物及其制备方法 |
EP2766423A1 (fr) * | 2011-10-12 | 2014-08-20 | Dow Global Technologies LLC | Forme posologique moulée par injection |
EP2797580A2 (fr) * | 2011-12-26 | 2014-11-05 | Novartis AG | Comprimés et agents enrobés à sec |
CN103349652B (zh) * | 2013-05-11 | 2014-11-19 | 辽宁大学 | 含有四氢萘酰胺化合物或其可药用盐的高药物载荷片剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
MY144477A (en) * | 2004-03-17 | 2011-09-30 | Novartis Ag | Galenic formulations of organic compounds |
ATE551052T1 (de) * | 2004-10-08 | 2012-04-15 | Novartis Ag | Verwendung von reninhemmern zur prävention oder behandlung von diastolischer dysfunktion oder diastolischer herzinsuffizienz |
MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
US20090247582A1 (en) * | 2005-04-27 | 2009-10-01 | Randy Lee Webb | Methods of treating atherosclerosis |
-
2008
- 2008-09-24 AU AU2008309058A patent/AU2008309058B2/en not_active Ceased
- 2008-09-24 JP JP2010527091A patent/JP2010540547A/ja not_active Withdrawn
- 2008-09-24 TW TW097136690A patent/TW200924737A/zh unknown
- 2008-09-24 AR ARP080104137A patent/AR066168A1/es not_active Application Discontinuation
- 2008-09-24 CA CA2698330A patent/CA2698330A1/fr not_active Abandoned
- 2008-09-24 PE PE2008001660A patent/PE20090654A1/es not_active Application Discontinuation
- 2008-09-24 BR BRPI0817442-3A patent/BRPI0817442A2/pt not_active IP Right Cessation
- 2008-09-24 WO PCT/US2008/077416 patent/WO2009045795A2/fr active Application Filing
- 2008-09-24 CN CN200880108860A patent/CN101808631A/zh active Pending
- 2008-09-24 US US12/678,877 patent/US20100209480A1/en not_active Abandoned
- 2008-09-24 CL CL2008002829A patent/CL2008002829A1/es unknown
- 2008-09-24 EP EP08835022A patent/EP2205233A2/fr not_active Withdrawn
- 2008-09-24 KR KR1020107006603A patent/KR20100063090A/ko not_active Application Discontinuation
- 2008-09-24 MX MX2010003441A patent/MX2010003441A/es not_active Application Discontinuation
-
2010
- 2010-03-17 MA MA32701A patent/MA31706B1/fr unknown
- 2010-03-26 TN TNP2010000135A patent/TN2010000135A1/fr unknown
- 2010-03-26 EC EC2010010052A patent/ECSP10010052A/es unknown
- 2010-04-19 CO CO10045487A patent/CO6270217A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2009045795A3 (fr) | 2009-07-16 |
WO2009045795A2 (fr) | 2009-04-09 |
KR20100063090A (ko) | 2010-06-10 |
BRPI0817442A2 (pt) | 2015-06-16 |
CL2008002829A1 (es) | 2009-06-26 |
PE20090654A1 (es) | 2009-06-27 |
ECSP10010052A (es) | 2010-04-30 |
TW200924737A (en) | 2009-06-16 |
AU2008309058B2 (en) | 2012-08-09 |
AR066168A1 (es) | 2009-07-29 |
CN101808631A (zh) | 2010-08-18 |
CO6270217A2 (es) | 2011-04-20 |
AU2008309058A1 (en) | 2009-04-09 |
CA2698330A1 (fr) | 2009-04-09 |
US20100209480A1 (en) | 2010-08-19 |
MX2010003441A (es) | 2010-04-21 |
MA31706B1 (fr) | 2010-09-01 |
JP2010540547A (ja) | 2010-12-24 |
EP2205233A2 (fr) | 2010-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2010000135A1 (en) | Galenical formulations of organic compounds | |
MX2010003439A (es) | Combinacion farmaceutica de aliskiren y valsartan. | |
WO2008040534A3 (fr) | Formes pharmaceutiques à base de film non muco-adhésif | |
MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
WO2007093183A3 (fr) | Procede de traitement de maladies inflammatoires | |
ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
WO2007138466A3 (fr) | Compositions pharmaceutiques comprenant une combinaison de meloxicam et de tramadol | |
MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
WO2007131070A3 (fr) | Compositions, formes pharmaceutiques et méthodes de traitement des vomissements | |
SG141358A1 (en) | Treatment of psychiatric patients with reduced heptaic function with paliperidone | |
IL187632A (en) | 17 – Ethinyl – 17 – Hydroxy – 13 – Methyl – 17,16,15,14,13,12,11,9,8,7 – Dachahydro – 6 h– Cyclopentane [a] Penanthran – 3 – Ilmethyl ester of acetoxy acid Acetic, a pharmaceutical dosage unit containing it and its use in the preparation of a contraceptive | |
WO2005120518A3 (fr) | Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires | |
JO3239B1 (ar) | تركيبات جالينية من مركبات عضوية | |
UA102111C2 (uk) | Фармацевтична композиція у вигляді разової пероральної дози, що містить леводопу, карбідопу і ентакапон або їх солі | |
TN2010000120A1 (en) | Galenical formulations of organic compounds | |
MX2009005804A (es) | Composicion farmaceutica de memantina. | |
MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. | |
TN2011000100A1 (en) | Galenical formulations of organic compounds | |
MX2011009846A (es) | Formulaciones galenicas de una combinacion de dosis fija de valsartan y alisquireno. | |
ZA201005394B (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative | |
TW200833375A (en) | Pharmaceutical compositions | |
WO2010027189A3 (fr) | Nouvelle utilisation d'homo-isoflavanone ou d'un sel associe | |
PL1817029T3 (pl) | Pochodna izoksazolowa do łagodzenia bólu neuropatycznego |